Court agrees with AbbVie’s methodology for damages in Takeda case
The Delaware Court of Chancery on Tuesday ruled in favor of AbbVie, likely setting up the drugmaker to receive most of the damages it was …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
